结核病预防和治疗的新时代:药物开发的突破和未来前景
Chun-Yan Zhao1,2, Chang Song1,2, Yi-Bo Lu3
1Department of Tuberculosis, The Fourth People's Hospital of Nanning, Nanning, 530023, Guangxi, China.
Infectious diseases and therapy
|September 3, 2025
概括
结核病药物开发显示了临床试验的显著增加,特别是在2018-2023年间. 尽管有新药,但传统药物占主导地位,全球研究资源的分配不均,需要注意公平的进步.
科学领域:
- 全球卫生研究
- * 制药开发
- * 传染病临床试验
背景情况:
- 结核病 (TB) 仍然是一个关键的全球卫生问题,需要在预防和治疗策略上不断创新.
- 缺乏对目前结核病药物开发临床试验的系统概述,这阻碍了战略规划.
- 最近药物开发的进展需要评估它们的科学价值和全球影响.
研究的目的:
- * 系统地回顾结核病药物研发的最新进展.
- * 评估这些进展的科学价值和全球影响.
- * 为参与结核病控制的临床医生和政策制定者提供见解.
主要方法:
- * 对结核病相关临床试验的INFORMA药物数据库进行系统搜索.
- *包括详细的药物机制或治疗目标的干预研究.
- *对试验特征进行数据选,提取和描述性统计分析.
主要成果:
- *从1990年至2025年期间观察到结核病临床试验的显著增加,在2018年至2023年期间达到顶峰.
- *中国和南非领导研究活动;美国和英国领导完成试验.
- 虽然Bedaquiline迅速发展,但传统药物占主导地位;学术机构是主要的资助者.
结论:
- 结核病药物开发环境充满活力,临床试验显著增长,研究方面存在区域差异.
- 持续的投资,公平的资源分配和政治承诺对于消除结核病至关重要.
- 全球协调的努力对于开启一个新的结核病预防和治疗时代至关重要.
相关概念视频
Pulmonary Tuberculosis V
237
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
237
Pulmonary Tuberculosis IV
202
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
202
Microorganisms in Medicine and Therapeutics
312
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
312
Pulmonary Tuberculosis II
343
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
343
Pulmonary Tuberculosis I
321
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
Pulmonary Tuberculosis III
439
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
439


